Servidei, Serenella
 Distribuzione geografica
Continente #
NA - Nord America 3.457
EU - Europa 3.037
AS - Asia 1.279
AF - Africa 28
OC - Oceania 17
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 9
Totale 7.840
Nazione #
US - Stati Uniti d'America 3.430
DE - Germania 890
SE - Svezia 631
CN - Cina 532
IT - Italia 429
SG - Singapore 370
UA - Ucraina 277
IE - Irlanda 237
FR - Francia 153
ID - Indonesia 141
GB - Regno Unito 102
FI - Finlandia 85
RU - Federazione Russa 81
IN - India 77
JP - Giappone 40
NL - Olanda 36
TR - Turchia 32
BE - Belgio 31
IR - Iran 19
HK - Hong Kong 18
ES - Italia 16
CA - Canada 15
AU - Australia 14
VN - Vietnam 14
AT - Austria 12
CI - Costa d'Avorio 11
ZA - Sudafrica 10
CZ - Repubblica Ceca 8
KR - Corea 7
LT - Lituania 7
MX - Messico 7
PL - Polonia 6
RO - Romania 6
CH - Svizzera 5
TH - Thailandia 5
BR - Brasile 4
CO - Colombia 4
EU - Europa 4
GR - Grecia 4
IL - Israele 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
HU - Ungheria 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
Totale 7.840
Città #
Chandler 705
Ashburn 403
Singapore 263
Dublin 236
San Mateo 206
Jacksonville 163
Jakarta 141
Nanjing 109
Boston 101
New York 95
Houston 94
Wilmington 90
Princeton 88
Rome 82
Ann Arbor 70
Woodbridge 65
Beijing 63
Munich 63
Redmond 61
Redwood City 60
Moscow 58
Nürnberg 54
Milan 52
Dearborn 45
Nanchang 39
Marseille 38
Seattle 38
Bremen 37
Lawrence 34
Norwalk 32
Fairfield 31
Cattolica 29
Izmir 29
Guangzhou 27
Hebei 27
Helsinki 27
Boardman 25
Kunming 25
Zhengzhou 23
Brussels 22
Mountain View 21
Chicago 20
Los Angeles 20
Hangzhou 19
Jiaxing 19
Pune 19
Changsha 18
Shanghai 17
University Park 17
Tianjin 16
Hanoi 14
Hong Kong 14
Shenyang 14
Lancaster 12
Abidjan 11
Detroit 10
Monza 10
Vienna 10
Andover 9
London 9
Waanrode 9
Augusta 8
Bari 8
Falkenstein 8
Leawood 8
Washington 8
Auburn Hills 7
Jinan 7
Berlin 6
Brno 6
Cambridge 6
Frankfurt am Main 6
Fremont 6
Mola di Bari 6
Naples 6
Sydney 6
Amsterdam 5
Brugherio 5
Changchun 5
Falls Church 5
Lanzhou 5
Ottawa 5
Seoul 5
Shahid 5
Tokyo 5
Zurich 5
Athens 4
Bangkok 4
Bogotá 4
Bristol 4
Busto Arsizio 4
Hadamar 4
Hefei 4
Lappeenranta 4
Las Vegas 4
Lodi 4
Ningbo 4
Nuremberg 4
Paris 4
Santa Barbara 4
Totale 4.366
Nome #
Creutzfeldt-Jakob disease manifesting as stroke mimic in a 78-year-old patient: Pitfalls and tips in the diagnosis 282
A rare case of life-threatening giant plexiform schwannoma 136
Hypoglossal palsy and coeliac disease: an uncommon presentation for a common disease? 131
"Myo-cardiomyopathy" is commonly associated with the A8344G "MERRF" mutation 128
A Case of Hemiabdominal Myoclonus 125
Neurological involvement during legionellosis, look beyond the lung 124
Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene 122
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 118
Copper deficiency myelopathy: A report of two cases 115
Mitochondrial neuropathy: considerations on pathogenesis 114
Restless Legs Syndrome with Periodic Limb Movements: a possible cause of idiopathic hyperCKemia. 112
Admission neurophysiological abnormalities in Guillain-Barré syndrome: A single-center experience 107
Muscle MRI in female carriers of dystrophinopathy 106
Neurological involvement during Legionellosis, look beyond the lung 104
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 102
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 99
P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis 97
Peripheral neuropathy is a common manifestation of mitochondrial diseases: a single-centre experience 97
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication 96
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene 96
Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride 96
Nerve growth factor eye drop administration improves visual function in a patient with optic glioma 91
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 91
Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration 90
Redefining phenotypes associated with mitochondrial DNA single deletion 87
Response to therapy in myasthenia gravis with anti-MuSK antibody 86
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 85
Intestinal pseudo-obstruction in mitochondrial diseases 84
A Case of Hemiabdominal Myoclonus 80
Bilateral thoracic long nerve involvement in motor multifocal neuropathy 77
Nutritional support in mitochondrial diseases: the state of the art 76
Acute auditory agnosia as the presenting hearing disorder in MELAS. 75
Clinical heterogeneity of seronegative myasthenia gravis 75
Acute necrotizing encephalopathy: a relapsing case in a European adult 73
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation 73
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 73
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 71
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 70
Spontaneous recovery from anti-NMDAR encephalitis 69
Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1 68
Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation 68
Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement 68
Subacute combined degeneration 67
Drug-resistant epilepsy in MELAS: safety and potential efficacy of lacosamide 67
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group 65
Midbrain panda sign in a patient with Wilson's disease 64
LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population 64
Isolated light chain deposition disease neuropathy in a patient with multiple myeloma 64
6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction 63
Osteoma of the internal auditory canal 62
Small fibre involvement in multifocal motor neuropathy explored with sudoscan: a single-centre experience 62
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 61
To the Editor: Fasciculations in Late-Onset Pompe Disease: A Sign of Motor Neuron Involvement? 61
Acute refractory intestinal pseudo-obstruction in melas: Efficacy of prucalopride 61
Recurrent miller fisher: a new case report and a literature review 61
Myasthenia gravis during interferon alfa therapy 60
Rasmussen encephalitis: an unusual cause for intractable seizures in elderly 60
Small fibre neuropathy in mitochondrial diseases explored with sudoscan 60
Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: A case report 58
Myoclonus in mitochondrial disorders 57
Frequency of Cerebrovascular Abnormalities in Patients with Late-Onset Pompe Disease: Our Experience 57
Spinal cord demyelination in children: A diagnostic challenge in neuropaediatrics for a good outcome 57
Expanding the spectrum of congenital myopathies: prenatal onset with extreme hyperextension of the neck 57
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 56
Drug-resistant epilepsy in MELAS: safety and potential efficacy of lacosamide 55
Macular impairment in mitochondrial diseases: a potential biomarker of disease severity 55
Sleep-Disordered Breathing in Adult Patients With Mitochondrial Diseases: A Cohort Study 54
Hospital admissions from the emergency department of adult patients affected by myopathies 53
Muscle MRI as a useful biomarker in hereditary transthyretin amyloidosis: A pilot study 53
Novel TOP3A Variant Associated With Mitochondrial Disease: Expanding the Clinical Spectrum of Topoisomerase III Alpha-Related Diseases 50
Migraine in mitochondrial disorders: Prevalence and characteristics 50
Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience 50
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 49
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 49
Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. 49
Sudoscan in the evaluation and follow-up of patients and carriers with TTR mutations: experience from an Italian Centre 49
Teaching Video NeuroImages: Palatal tremor associated with SPG7 variants 48
Focal status epilepticus as unique clinical feature of COVID-19: A case report 48
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 47
Epilepsy management in mitochondrial diseases 46
Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2 45
Patisiran in hereditary transthyretin-mediated amyloidosis 45
Mitochondrial encephalomyopathies:gene mutation 44
Genotype-phenotype correlation in Pompe disease, a step forward 43
Awareness of rare and genetic neurological diseases among italian neurologist. A national survey 43
Spinal cord involvement in adult mitochondrial diseases: A cohort study 43
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia 42
Patisiran in hereditary transthyretin-mediated amyloidosis 40
A new de novo missense mutation in MYH2 expands clinical and genetic findings in hereditary myosin myopathies 39
Muscle pain in mitochondrial diseases: a picture from the Italian network 39
Limb-Girdle Muscular Dystrophies (LGMDs): The Clinical Application of NGS Analysis, a Family Case Report 39
Progressive axonal polyneuropathy in a mitochondrial disorder: an uncommon association with familial amyloid neuropathy 38
Correction to: Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efficacy and literature review 38
Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy 37
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency 37
Mitochondrial epilepsy: a cross-sectional nationwide Italian survey 37
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1 36
Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine 35
Fourier-transform infrared spectroscopy of skeletal muscle tissue: Expanding biomarkers in primary mitochondrial myopathies 35
Incomplete penetrance in a SPG3A-linked family with a new mutation in the atlastin gene 34
Totale 7.075
Categoria #
all - tutte 41.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020384 0 0 0 0 0 0 56 30 68 63 96 71
2020/2021643 25 59 8 67 77 31 104 17 70 34 135 16
2021/2022981 80 48 9 62 52 32 8 198 38 53 183 218
2022/20231.949 259 260 150 296 115 280 65 138 266 33 63 24
2023/20241.316 58 347 33 180 34 185 65 48 15 52 157 142
2024/2025694 58 68 214 114 139 90 11 0 0 0 0 0
Totale 8.034